Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium

DOI: 10.1186/1465-9921-13-52

Keywords: Randomisation, Blinded, Blinding, Open-label, Indacaterol, Tiotropium, COPD

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text